FundedIQ
Biotechnology

Definitive Diagnostics: Funding, Investors & Team (Oct 2026)

The Definitive Diagnostics platform is able to detect the most common types of cancer, such as breast, lung, and colorectal, as well as more aggressive forms like pancreatic and ovarian cancer.

definitivedx.bio LinkedIn New York, United States 1-10 employees
Total raised
$100k
Rounds
1
Latest
Seed
May 2024

Definitive Diagnostics has raised $100k across 1 funding round on record, the most recent a Seed of $100k announced in May 2024.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Definitive Diagnostics Company Profile and Key Stats

Total funding raised
$100k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$100k in May 2024
Employees
1-10
reported band
Headquarters
New York, United States

Latest funding round on record: May 2024.

Definitive Diagnostics Funding Rounds

Date
Round
Amount
Seed
$100k

Definitive Diagnostics Founders and Leadership Team

Name
Role
Contact
Ellis Malovany
Founder
—

No contact details are on record for this team yet.

Definitive Diagnostics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
17,153
$3.1M

Definitive Diagnostics' latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Definitive Diagnostics in Biotechnology and New York

Companies Similar to Definitive Diagnostics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Definitive Diagnostics Funding FAQs

What does Definitive Diagnostics do?

The Definitive Diagnostics platform is able to detect the most common types of cancer, such as breast, lung, and colorectal, as well as more aggressive forms like pancreatic and ovarian cancer.

How much funding has Definitive Diagnostics raised?

Definitive Diagnostics has raised $100k across 1 round on record. The most recent is a Seed of $100k announced in May 2024.

When did Definitive Diagnostics last raise funding?

Definitive Diagnostics' most recent funding round on record is a Seed of $100k, announced in May 2024.

Who founded Definitive Diagnostics?

FundedIQ lists Ellis Malovany (Founder) at Definitive Diagnostics.

Where is Definitive Diagnostics headquartered?

Definitive Diagnostics is based in New York, United States.

How many employees does Definitive Diagnostics have?

Definitive Diagnostics is in the 1-10 employee band.

How does Definitive Diagnostics' funding compare to other Biotechnology startups?

Definitive Diagnostics' latest round of $100k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Definitive Diagnostics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Definitive Diagnostics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.